Gisela Paulsen - Net Worth and Insider Trading

Gisela Paulsen Net Worth

The estimated net worth of Gisela Paulsen is at least $2,351 dollars as of 2024-09-30. Gisela Paulsen is the COO of OncoCyte Corp and owns about 825 shares of OncoCyte Corp (OCX) stock worth over $2,351. Details can be seen in Gisela Paulsen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gisela Paulsen has not made any transactions after 2022-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gisela Paulsen

To

Gisela Paulsen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gisela Paulsen owns 2 companies in total, including Exact Sciences Corp (EXAS) , and OncoCyte Corp (OCX) .

Click here to see the complete history of Gisela Paulsen’s form 4 insider trades.

Insider Ownership Summary of Gisela Paulsen

Ticker Comapny Transaction Date Type of Owner
EXAS Exact Sciences Corp 2020-04-20 Gen Mgr & Precision Oncology
OCX OncoCyte Corp 2022-03-17 Chief Operating Officer

Gisela Paulsen Latest Holdings Summary

Gisela Paulsen currently owns a total of 1 stock. Gisela Paulsen owns 825 shares of OncoCyte Corp (OCX) as of March 17, 2022, with a value of $2,351.

Latest Holdings of Gisela Paulsen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2022-03-17 825 2.85 2,351

Holding Weightings of Gisela Paulsen


Gisela Paulsen Form 4 Trading Tracker

According to the SEC Form 4 filings, Gisela Paulsen has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 825 shares on March 17, 2022, which cost Gisela Paulsen around $19,800.

Insider Trading History of Gisela Paulsen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gisela Paulsen Trading Performance

GuruFocus tracks the stock performance after each of Gisela Paulsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gisela Paulsen is -28%. GuruFocus also compares Gisela Paulsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gisela Paulsen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gisela Paulsen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gisela Paulsen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Gisela Paulsen Ownership Network

Ownership Network List of Gisela Paulsen

No Data

Ownership Network Relation of Gisela Paulsen

Insider Network Chart

Gisela Paulsen Owned Company Details

What does Exact Sciences Corp do?

Who are the key executives at Exact Sciences Corp?

Gisela Paulsen is the Gen Mgr & Precision Oncology of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , General Manager & New Ventures Jacob A Orville , and SVP & Human Resources Sarah Condella .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Gisela Paulsen made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 28,371 shares made by Sarah Condella , a net sale of 10,530 shares made by Brian Baranick , and a net sale of 6,703 shares made by James Herriott .

In summary, during the past 3 months, insiders sold 929 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 929 shares. During the past 18 months, 183,810 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,810 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exact Sciences Corp Insider Transactions

No Available Data

Gisela Paulsen Mailing Address

Above is the net worth, insider trading, and ownership report for Gisela Paulsen. You might contact Gisela Paulsen via mailing address: 5505 Endeavor Lane, Madison Wi 53719.

Discussions on Gisela Paulsen

No discussions yet.